Elevation Oncology Inc.

NASDAQ: ELEV · Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM

Elevation Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-44.48M -45.7M -95.08M -32.04M
Depreciation & Amortization
24K 39K 27K 18K
Stock-Based Compensation
4.28M 3.33M 3.21M 1.57M
Other Working Capital
3.79M -7.83M 5.58M 313K
Other Non-Cash Items
-22K -160K 74K 1.64M
Deferred Income Tax
n/a n/a n/a -1.64M
Change in Working Capital
3.84M -13.69M 6.29M 283K
Operating Cash Flow
-36.36M -56.18M -85.48M -30.17M
Capital Expenditures
n/a n/a -86K n/a
Cash Acquisitions
n/a n/a 44.31K n/a
Purchase of Investments
-69.56M -42.66M -112.31M n/a
Sales Maturities Of Investments
61.2M 54.2M 68M n/a
Other Investing Acitivies
n/a n/a -44.31K n/a
Investing Cash Flow
-8.37M 11.54M -44.4M n/a
Debt Repayment
n/a n/a 30M n/a
Common Stock Repurchased
-48K -24K -35K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
779K 1.5M -451K -11K
Financial Cash Flow
44.94M 47.98M 29.51M 97.05M
Net Cash Flow
209K 3.34M -100.37M 66.88M
Free Cash Flow
-36.36M -56.18M -85.57M -30.17M